12:00 AM
 | 
Jun 28, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Axis-Shield, Bouty Healthcare S.p.A. sales and marketing update

Bouty's Technogenetics s.r.l. division launched an automated anti-CCP test outside the U.S. for the early detection of rheumatoid arthritis (RA). The...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >